Vaccine value profile for Salmonella enterica serovar Paratyphi A.

Martin, Laura B; Khanam, Farhana; Qadri, Firdausi; Khalil, Ibrahim; Sikorski, Michael J; Baker, Stephen

Martin, Laura B; Khanam, Farhana; Qadri, Firdausi; Khalil, Ibrahim; Sikorski, Michael J; Baker, Stephen.

Afiliação

Martin LB; Independent Consultant (current affiliation US Pharmacopeia Convention), USA. Electronic address: LauraBMartin@vacc4impact.science.
Khanam F; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh. Electronic address: farhanak@icddrb.org.
Qadri F; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh. Electronic address: fqadri@icddrb.org.
Khalil I; University of Washington, USA. Electronic address: ikhalil@uw.edu.
Sikorski MJ; University of Maryland School of Medicine, USA. Electronic address: michael.sikorski@som.umaryland.edu.
Baker S; University of Cambridge School of Clinical Medicine, UK. Electronic address: sgb47@cam.ac.uk.

Vaccine ; 41 Suppl 2: S114-S133, 2023 11 03.

Article em En | MEDLINE | ID: mdl-37951691

Assuntos

Febre Paratifoide; Vacinas contra Salmonella; Febre Tifoide; Vacinas Tíficas-Paratíficas; Adulto; Criança; Humanos; Pré-Escolar; Pessoa de Meia-Idade; Salmonella paratyphi A; Febre Paratifoide/prevenção & controle; Febre Paratifoide/epidemiologia; Febre Paratifoide/microbiologia; Salmonella typhi

Palavras-chave

Paratyphoid; Salmonella enterica serovar Paratyphi A; Vaccine; Vaccine value profile: paratyphoid fever

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Tifoide / Vacinas Tíficas-Paratíficas / Febre Paratifoide / Vacinas contra Salmonella Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google